This report contains market size and forecasts of Biosimilar Monoclonal Antibody in Global, including the following market information:
Global Biosimilar Monoclonal Antibody Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Biosimilar Monoclonal Antibody market was valued at 4706.7 million in 2020 and is projected to reach US$ 12060 million by 2027, at a CAGR of 26.5% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilar Monoclonal Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Monoclonal Antibody Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Biosimilar Monoclonal Antibody Market Segment Percentages, By Type, 2020 (%)
Limited Dilution Method
Micromanipulation
Soft Agar Plate Method
Others
China Biosimilar Monoclonal Antibody Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Biosimilar Monoclonal Antibody Market Segment Percentages, By Application, 2020 (%)
Chronic & Autoimmune Diseases
Oncology
Others
Global Biosimilar Monoclonal Antibody Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Biosimilar Monoclonal Antibody Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Biosimilar Monoclonal Antibody Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Biosimilar Monoclonal Antibody Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Monoclonal Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Monoclonal Antibody Overall Market Size
2.1 Global Biosimilar Monoclonal Antibody Market Size: 2021 VS 2027
2.2 Global Biosimilar Monoclonal Antibody Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Monoclonal Antibody Players in Global Market
3.2 Top Global Biosimilar Monoclonal Antibody Companies Ranked by Revenue
3.3 Global Biosimilar Monoclonal Antibody Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Monoclonal Antibody Companies in Global Market, by Revenue in 2020
3.5 Global Companies Biosimilar Monoclonal Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Monoclonal Antibody Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Monoclonal Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilar Monoclonal Antibody Market Size Markets, 2021 & 2027
4.1.2 Limited Dilution Method
4.1.3 Micromanipulation
4.1.4 Soft Agar Plate Method
4.1.5 Others
4.2 By Type - Global Biosimilar Monoclonal Antibody Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Monoclonal Antibody Revenue, 2016-2021
4.2.2 By Type - Global Biosimilar Monoclonal Antibody Revenue, 2022-2027
4.2.3 By Type - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Monoclonal Antibody Market Size, 2021 & 2027
5.1.2 Chronic & Autoimmune Diseases
5.1.3 Oncology
5.1.4 Others
5.2 By Application - Global Biosimilar Monoclonal Antibody Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Monoclonal Antibody Revenue, 2016-2021
5.2.2 By Application - Global Biosimilar Monoclonal Antibody Revenue, 2022-2027
5.2.3 By Application - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Biosimilar Monoclonal Antibody Market Size, 2021 & 2027
6.2 By Region - Global Biosimilar Monoclonal Antibody Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Monoclonal Antibody Revenue, 2016-2021
6.2.2 By Region - Global Biosimilar Monoclonal Antibody Revenue, 2022-2027
6.2.3 By Region - Global Biosimilar Monoclonal Antibody Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Biosimilar Monoclonal Antibody Revenue, 2016-2027
6.3.2 US Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.3.3 Canada Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.3.4 Mexico Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Biosimilar Monoclonal Antibody Revenue, 2016-2027
6.4.2 Germany Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4.3 France Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4.4 U.K. Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4.5 Italy Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4.6 Russia Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4.7 Nordic Countries Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.4.8 Benelux Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Biosimilar Monoclonal Antibody Revenue, 2016-2027
6.5.2 China Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.5.3 Japan Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.5.4 South Korea Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.5.5 Southeast Asia Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.5.6 India Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Biosimilar Monoclonal Antibody Revenue, 2016-2027
6.6.2 Brazil Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.6.3 Argentina Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Monoclonal Antibody Revenue, 2016-2027
6.7.2 Turkey Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.7.3 Israel Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.7.4 Saudi Arabia Biosimilar Monoclonal Antibody Market Size, 2016-2027
6.7.5 UAE Biosimilar Monoclonal Antibody Market Size, 2016-2027
7 Players Profiles
7.1 Biocon
7.1.1 Biocon Corporate Summary
7.1.2 Biocon Business Overview
7.1.3 Biocon Biosimilar Monoclonal Antibody Major Product Offerings
7.1.4 Biocon Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.1.5 Biocon Key News
7.2 Accord Healthcare
7.2.1 Accord Healthcare Corporate Summary
7.2.2 Accord Healthcare Business Overview
7.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Major Product Offerings
7.2.4 Accord Healthcare Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.2.5 Accord Healthcare Key News
7.3 AET Biotech
7.3.1 AET Biotech Corporate Summary
7.3.2 AET Biotech Business Overview
7.3.3 AET Biotech Biosimilar Monoclonal Antibody Major Product Offerings
7.3.4 AET Biotech Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.3.5 AET Biotech Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Biosimilar Monoclonal Antibody Major Product Offerings
7.4.4 Amgen Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.4.5 Amgen Key News
7.5 Celltrion
7.5.1 Celltrion Corporate Summary
7.5.2 Celltrion Business Overview
7.5.3 Celltrion Biosimilar Monoclonal Antibody Major Product Offerings
7.5.4 Celltrion Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.5.5 Celltrion Key News
7.6 Reddy's Laboratories
7.6.1 Reddy's Laboratories Corporate Summary
7.6.2 Reddy's Laboratories Business Overview
7.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Major Product Offerings
7.6.4 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.6.5 Reddy's Laboratories Key News
7.7 Hospira
7.7.1 Hospira Corporate Summary
7.7.2 Hospira Business Overview
7.7.3 Hospira Biosimilar Monoclonal Antibody Major Product Offerings
7.4.4 Hospira Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.7.5 Hospira Key News
7.8 3SBio
7.8.1 3SBio Corporate Summary
7.8.2 3SBio Business Overview
7.8.3 3SBio Biosimilar Monoclonal Antibody Major Product Offerings
7.8.4 3SBio Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.8.5 3SBio Key News
7.9 Allergan
7.9.1 Allergan Corporate Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Biosimilar Monoclonal Antibody Major Product Offerings
7.9.4 Allergan Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.9.5 Allergan Key News
7.10 Alvartis
7.10.1 Alvartis Corporate Summary
7.10.2 Alvartis Business Overview
7.10.3 Alvartis Biosimilar Monoclonal Antibody Major Product Offerings
7.10.4 Alvartis Biosimilar Monoclonal Antibody Revenue in Global (2016-2021)
7.10.5 Alvartis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Biosimilar Monoclonal Antibody Market Opportunities & Trends in Global Market
Table 2. Biosimilar Monoclonal Antibody Market Drivers in Global Market
Table 3. Biosimilar Monoclonal Antibody Market Restraints in Global Market
Table 4. Key Players of Biosimilar Monoclonal Antibody in Global Market
Table 5. Top Biosimilar Monoclonal Antibody Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Biosimilar Monoclonal Antibody Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Biosimilar Monoclonal Antibody Revenue Share by Companies, 2016-2021
Table 8. Global Companies Biosimilar Monoclonal Antibody Product Type
Table 9. List of Global Tier 1 Biosimilar Monoclonal Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Monoclonal Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type